Losartan Cost in Minnesota 2026: Cash Price, Medicaid, Insurance, and Discount Options

What Losartan Is and Why Pricing Varies by State

Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for three indications: hypertension, reduction of stroke risk in patients with left ventricular hypertrophy (LVH), and diabetic nephropathy in type 2 diabetes patients with proteinuria [1]. The FDA first approved Cozaar (losartan potassium, Merck) in 1995 [1]. Generic versions have been available since 2010, and competition among manufacturers has pushed cash prices sharply downward.

State-level pricing differs because Medicaid reimbursement rates, pharmacy benefit manager (PBM) contracts, and 340B program participation vary by state. Minnesota's comparatively large number of Federally Qualified Health Centers (FQHCs) and its strong Medicaid program (Medical Assistance, or MA) give residents more low-cost pathways than many other states.

The LIFE trial (Losartan Intervention For Endpoint reduction in hypertension, N=9,193, Lancet 2002) established losartan's cardiovascular outcomes profile, showing a 13% relative risk reduction in the composite of cardiovascular death, myocardial infarction, and stroke compared with atenolol over a mean of 4.8 years [2]. That evidence base underpins why every major U.S. guideline includes ARBs as first-line antihypertensives, which in turn drives formulary placement.

The 2017 ACC/AHA Hypertension Guideline states: "ARBs are recommended as first-line therapy for hypertension in patients with CKD to slow kidney disease progression" [3]. That recommendation directly affects whether insurers and Medicaid programs are willing to cover losartan without step therapy.

Hypertension affects approximately 47% of U.S. adults, according to CDC data [4]. In Minnesota, an estimated 31% of adults carry a hypertension diagnosis [4], making losartan one of the highest-volume generic prescriptions dispensed in the state.

Generic Losartan Cash Price in Minnesota in 2026

Generic losartan runs about $10 per month in Minnesota for a standard 50 mg, 30-tablet supply when purchased cash-pay at retail pharmacies in 2026. Prices shift by dose and quantity.

At 25 mg (30 tablets), cash prices at major Minnesota chains typically fall between $9 and $12. At 100 mg (30 tablets), expect $11 to $18, since fewer manufacturers produce the higher-strength tablet at scale. Purchasing a 90-day supply usually lowers the per-tablet cost by 10 to 20% [5].

Warehouse-club pharmacies (Costco, Sam's Club) often post the lowest cash prices in the Twin Cities metro, sometimes as low as $7 for a 30-day supply of 50 mg. Independently operated pharmacies outside the metro can be higher, occasionally $18, $22, because they lack the volume purchasing use of large chains.

Mail-order programs through CVS Caremark, Express Scripts, and OptumRx regularly offer 90-day generic losartan supplies for $20, $30 when processed through a commercial insurance plan [6]. Without insurance, those same mail-order programs price the 90-day supply at $25, $35 cash, still significantly below the brand list price.

Cozaar (Brand) vs. Generic: What Minnesota Patients Actually Pay

Merck's branded Cozaar carries a list price near $80 per month [7]. Almost no commercially insured patient in Minnesota pays that figure. Generic substitution is automatic at virtually every Minnesota pharmacy unless the prescriber writes "dispense as written" on the script. Even if a prescriber does write for brand, most pharmacy benefit managers apply a mandatory generic substitution rule.

The LIFE trial used losartan 50 mg titrated to 100 mg, the same doses available generically today [2]. No clinical evidence supports brand Cozaar over generic losartan potassium for outcomes, and the FDA's bioequivalence standards require the generic to perform within 80 to 125% of the brand's pharmacokinetic parameters [8].

Patients who specifically want brand Cozaar and pay cash should expect $70, $90 per month in Minnesota after any manufacturer coupon. Merck does offer a savings card for eligible commercially insured patients, but it explicitly excludes patients covered by federal programs, including Medicare Part D and Medicaid [9].

Minnesota Medicaid (Medical Assistance) Coverage for Losartan

Minnesota's Medical Assistance program covers losartan with prior authorization (PA). The PA requirement exists because the Minnesota Department of Human Services (DHS) places several ARBs on the Preferred Drug List (PDL) with quantity and step-therapy criteria [10]. In practice, PA is approved quickly when the prescriber documents a qualifying diagnosis (hypertension, CKD with proteinuria, or LVH-associated stroke risk) and confirms the patient has tried at least one ACE inhibitor or documents intolerance.

ACE inhibitor cough affects approximately 10 to 15% of patients on those drugs, and the rate is higher in patients of Asian descent [11]. Minnesota's Hmong, Chinese, Korean, and South Asian communities represent a meaningful share of the MA population, making losartan's ACE-inhibitor-alternative status clinically and policy-relevant.

Once PA is approved, out-of-pocket cost for MA enrollees is $0 to $3 per prescription under Minnesota's nominal cost-sharing rules [10]. MinnesotaCare, the state's Basic Health Program for individuals with incomes between 138% and 200% of the federal poverty level, also covers losartan; its cost-sharing structure caps drug copays at $3 [10].

The DHS Preferred Drug List is updated quarterly. Providers can verify current PA criteria at the Minnesota DHS pharmacy portal, and patients can request a PA exception through their prescribing clinician.

Commercial Insurance Tiers for Losartan in Minnesota

Most commercial plans sold on Minnesota's health insurance exchange (MNsure) and employer-sponsored plans administered by major carriers (Blue Cross Blue Shield of Minnesota, HealthPartners, Medica, PreferredOne, UCare) place generic losartan on Tier 1 of their formularies [6].

Tier 1 copays typically range from $0 to $15 per 30-day fill, depending on the plan's cost-sharing design. High-deductible health plans (HDHPs) require the enrollee to pay the full contracted rate until the deductible is met; that contracted rate is usually $9, $14 for generic losartan at in-network pharmacies, which is close to the cash price anyway.

Preferred provider organization (PPO) and health maintenance organization (HMO) plans with low-deductible structures commonly charge $0, $5 for Tier 1 generics. A 2022 analysis of Part D formularies found that ARBs were covered by 99.7% of plans reviewed, with a median copay of $0 for low-income subsidy (LIS) enrollees [12].

Medicare Part D in Minnesota mirrors that pattern. The Low Income Subsidy (Extra Help) program reduces losartan copays to $0, $4.30 for full-subsidy recipients in 2026 [13].

Compounded Losartan in Minnesota: Legality and Cost

Compounded losartan is legal in Minnesota when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription [14]. The FDA's 503A framework (Section 503A of the Federal Food, Drug, and Cosmetic Act) permits licensed pharmacists to compound drug products for identified individual patients, provided the active pharmaceutical ingredient (API) meets USP standards and the compound is not a copy of a commercially available product [14].

Losartan in its commercially available oral tablet form is not classified as a drug on the FDA's shortage list, which means compounding pharmacies cannot produce it in bulk as a 503B outsourcing facility product. However, 503A pharmacies can compound alternative dose strengths, combination formulations (for example, losartan plus hydrochlorothiazide at a non-standard ratio), or alternative delivery forms when a prescriber documents a clinical rationale [14].

The Minnesota Board of Pharmacy licenses and inspects 503A pharmacies within the state. Out-of-state 503A pharmacies may also ship to Minnesota patients, provided they hold a Minnesota non-resident pharmacy permit [15]. Patients should verify licensure before ordering from any compounding pharmacy.

Cost for compounded losartan varies widely. Some telehealth platforms that integrate 503A pharmacy partnerships offer compounded losartan at $0 to $20 per month, subsidized through platform membership fees. Standard 503A compounding without a subsidy runs $30, $60 per month for custom formulations, which is higher than generic retail but may be clinically appropriate for patients needing non-standard doses.

Telehealth Prescribing of Losartan in Minnesota

Minnesota law permits telehealth prescribing of losartan for hypertension management. The Minnesota Telehealth Act (Minn. Stat. § 62A.673) requires that telehealth services meet the same standard of care as in-person visits, but it does not impose a mandatory in-person initial visit requirement for prescribing non-controlled substances [16].

Federal Ryan Haight Act provisions apply only to controlled substances; losartan is not a controlled substance. Prescribers licensed in Minnesota (or holding a multi-state license under the Interstate Medical Licensure Compact, IMLC) may initiate and manage losartan therapy via synchronous audio-video visits [16].

Blood pressure measurement is the primary monitoring tool for losartan management. Home blood pressure monitors meeting American Heart Association validation standards cost $30, $80 at retail and allow remote management without in-office visits [17]. The AHA recommends home readings for all patients on antihypertensive therapy, taken in a seated position after 5 minutes of rest, twice daily for at least 1 week before and after any medication change [17].

Potassium monitoring is also standard practice for ARB therapy. A baseline comprehensive metabolic panel (CMP) and repeat testing at 2 to 4 weeks after initiation are appropriate, which a telehealth provider can order through a local lab draw site [18].

Discount Programs and Patient Assistance for Minnesota Residents

GoodRx and similar coupon aggregators. GoodRx, RxSaver, and SingleCare publish real-time discount codes that reduce losartan cash prices at Minnesota pharmacies. GoodRx's Minnesota benchmark for losartan 50 mg (30 tablets) ranges from $9 at Costco to $14 at chain drugstores [5]. These coupons cannot be combined with insurance but are often cheaper than insurance copays for patients who have not met their deductible.

NeedyMeds. NeedyMeds maintains a database of patient assistance programs (PAPs) for branded medications. Merck's PAP for Cozaar covers uninsured patients below 400% of the federal poverty level, providing brand-name medication at no charge [9]. Enrollment requires prescriber documentation and annual renewal.

Minnesota RxConnect. Minnesota's state pharmaceutical assistance program coordinates with manufacturer PAPs to help low-income residents access medications. It serves residents who fall in the gap between Medicaid eligibility and commercial insurance affordability [19].

340B Drug Pricing Program. FQHCs, rural health clinics, and other 340B-covered entities in Minnesota can dispense losartan to eligible patients at 340B prices, which are significantly below wholesale acquisition cost. Hennepin Healthcare, CentraCare, and numerous community health centers across Minnesota participate in 340B [20]. Eligible patients include uninsured individuals and those meeting low-income criteria set by each covered entity.

Mark Cuban Cost Plus Drugs. Cost Plus Drugs (costplusdrugs.com) lists losartan 50 mg (90 tablets) at approximately $7, $11 through their transparent pricing model. Minnesota residents can use Cost Plus as a cash-pay option when their provider sends a prescription to a participating pharmacy [5].

The table below summarizes the primary cost pathways for Minnesota residents, ordered from lowest expected out-of-pocket cost to highest:

| Pathway | Expected Monthly Cost (MN, 2026) | |---|---| | Minnesota Medical Assistance (MA) with approved PA | $0, $3 | | Compounded losartan via telehealth platform (subsidized) | $0, $20 | | 340B FQHC dispensing (eligible patients) | $0, $5 | | Medicare Part D with Low Income Subsidy (Extra Help) | $0, $4.30 | | Commercial insurance Tier 1 copay (non-HDHP) | $0, $15 | | GoodRx / Cost Plus cash-pay (generic, 50 mg, 30 tabs) | $9, $14 | | Commercial insurance HDHP before deductible | $9, $14 | | Generic losartan, no coupon, no insurance | $10, $22 | | Compounded losartan (unsubsidized 503A) | $30, $60 | | Brand Cozaar, cash pay | $70, $90 |

Losartan Dosing, Clinical Evidence, and Safety Context

Losartan is dosed once daily. For hypertension, the starting dose is typically 50 mg once daily; the prescriber may titrate to 100 mg if blood pressure targets are not achieved [1]. For patients with intravascular volume depletion (for example, those on diuretics), the starting dose is 25 mg [1].

In the LIFE trial, patients started at 50 mg and were titrated to 100 mg plus hydrochlorothiazide 12.5 to 25 mg if needed. The primary composite endpoint (cardiovascular death, MI, or stroke) occurred in 508 patients on losartan vs. 588 on atenolol, a 13% relative risk reduction (P<0.001) [2]. The benefit was driven largely by stroke reduction.

For diabetic nephropathy, the RENAAL trial (N=1,513, NEJM 2001) showed that losartan 50 to 100 mg reduced the composite of doubling of serum creatinine, ESRD, or death by 16% compared with placebo in patients with type 2 diabetes and nephropathy (P=0.02) [21]. Urinary albumin excretion also fell by 35% at 6 months [21].

Common adverse effects include dizziness (particularly with the first dose), hyperkalemia, and elevated serum creatinine in patients with bilateral renal artery stenosis [1]. The risk of hyperkalemia increases when losartan is combined with potassium-sparing diuretics, potassium supplements, or other agents that raise serum potassium [18]. The FDA label carries a boxed warning for fetal toxicity; losartan is contraindicated in pregnancy [1].

Unlike ACE inhibitors, losartan does not cause angioedema through bradykinin accumulation; the bradykinin-mediated cough seen with ACE inhibitors is largely absent with ARBs. A meta-analysis published in the British Medical Journal (BMJ, 2012) covering 125,000 patients found an ARB-associated cough rate of 3.2% vs. 11.5% for ACE inhibitors [22].

How to Reduce Your Losartan Cost in Minnesota: A Step-by-Step Approach

Start by confirming whether you qualify for Minnesota Medical Assistance or MinnesotaCare. If your household income is at or below 138% of the federal poverty level, MA likely covers your medications, and losartan PA approval is routine with a hypertension or CKD diagnosis.

If you have commercial insurance, ask your pharmacist to run the prescription through your plan before accepting any cash price. Also ask them to check GoodRx simultaneously, since coupon pricing occasionally beats the insurance copay, especially for patients still in their deductible period.

If you are uninsured and do not qualify for MA, check whether any FQHC in your county participates in 340B. Minnesota has more than 40 FQHC service sites; 340B pricing can bring losartan to near-zero cost for eligible patients [20].

Telehealth platforms that partner with 503A compounding pharmacies may offer losartan as part of a bundled membership. Compare the total monthly platform fee plus drug cost against your retail cash price before enrolling. For most patients already paying $10/month at retail, the math rarely favors a bundled platform.

Request a 90-day supply when possible. The per-unit cost drops, and fewer trips to the pharmacy reduce the risk of treatment gaps. Blood pressure control is continuous; a 90-day fill eliminates the risk of a coverage lapse around a 30-day refill deadline [17].